ALB and liver disorder: Although a number of biomarkers including albumin, platelets, hyaluronic acid and AST have been evaluated, there is currently no single marker which successfully predicts significant fibrosis in HBV-related liver disease, and multiple biomarkers are needed to complement clinical data [7].